Advertisement

Applied Nanoscience

, Volume 8, Issue 6, pp 1493–1504 | Cite as

Bimetallic redox nanoprobe enhances the therapeutic efficacy of hyperthermia in drug-resistant cancer cells

  • Sandeep Kumar Vishwakarma
  • Chandrakala Lakkireddy
  • Tuba Marjan
  • Anjum Fatima
  • Avinash Bardia
  • Syed Ameer Basha Paspala
  • Md. Aejaz Habeeb
  • Aleem Ahmed Khan
Original Article
  • 5 Downloads

Abstract

Cancer nanotheranostics has emerged as one of the most promising fields of medicine wherein nano-sized molecules/agents are used for combined diagnosis and treatment of cancer. Despite promises of novel cancer therapeutic approaches, several crucial challenges have remained to be overcome for successful clinical translation of such agents. Hence, the present study has been aimed to investigate the therapeutic efficacy of bimetallic gadolinium super-paramagnetic iron oxide nanoformulation of ascorbic acid in synergism with hyperthermia on ascorbic acid-resistant breast cancer cells. This particular strategy provides real-time MRI-based non-invasive imaging of drug loading in resistant cancer cells along with highly enhanced therapeutic efficacy. This unique redox nanoprobe is capable of reversing drug-resistance mechanism in cancer cells and offers better therapeutic possibilities in targeted and effective destruction of drug-resistant cancer cells.

Keywords

Drug-resistance cancer Redox nanoprobe Hyperthermia Treatment Bimetallic nanoparticles 

Notes

Acknowledgements

The authors thank the Department of Radiology, Princess Esra Hospital, Hyderabad, for providing facility to conduct MRI contrast imaging.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. Athar T, Vishwakarma SK, Bardia A, Khan AA (2016) Super paramagnetic iron oxide and gadolinium (FeGdO3) nanopowder synthesized by hydrolytic approach passes high level of biocompatibility and MRI-based dual contrast property for competent molecular imaging and therapeutic interventions. Biomed Phys Eng Express 2:025010CrossRefGoogle Scholar
  2. Chen H, Zhang W, Zhu G, Xie J, Chen X (2017) Rethinking cancer nanotheranostics. Nat Rev Mater 2:17024CrossRefGoogle Scholar
  3. Conde J, Tian F, De la Fuente JM, Baptista PV (2016) Editorial: cancer nanotheranostics: what have we learned so far? Front Chem 3:71CrossRefGoogle Scholar
  4. Dissanayake NM, Current KM, Obare SO (2015) Mutagenic effects of iron oxide nanoparticles on biological cells. Int J Mol Sci 16:23482–23516CrossRefGoogle Scholar
  5. Fei L, Perrett S (2009) Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci 10:646–655CrossRefGoogle Scholar
  6. Gajbhiye KR, Gajbhiye V, Siddiqui IA, Pilla S, Soni V (2017) Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: an in vitro-in vivo study. Sci Rep 7:11086CrossRefGoogle Scholar
  7. Hervault A, Thanh NTK (2014) Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale 6:11553–11573CrossRefGoogle Scholar
  8. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43:33–56CrossRefGoogle Scholar
  9. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers (Basel) 6:1769–1792CrossRefGoogle Scholar
  10. Itoh Y, Yamada Y, Kazaoka Y, Ishiguchi T, Honda N (2010) Combination of chemotherapy and mild hyperthermia enhances the anti-tumor effects of cisplatin and adriamycin in human bladder cancer T24 cells in vitro. Exp Ther Med 1:319–323CrossRefGoogle Scholar
  11. Jaramillo AC, Saig FA, Cloos J, Jansen G, Peters GJ (2018) How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance? Cancer Drug Resist 1:6–29CrossRefGoogle Scholar
  12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefGoogle Scholar
  13. Krolikowska A, Kudelski A, Michota A, Bukowska J (2003) SERS studies on the structure of thioglycolic acid monolayers on silver and gold. Surf Sci 532:227–232CrossRefGoogle Scholar
  14. Kuiper C, Vissers MCM (2014) Ascorbate as a co-factor for Fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol 4:359Google Scholar
  15. Kumar V, Yadav SK (2009) Plant-mediated synthesis of silver and gold nanoparticles and their applications. J Chem Technol Biotechnol 84:151–157CrossRefGoogle Scholar
  16. Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, Doroshow JH (2012) Advances in using PARP inhibitors to treat cancer. BMC Med 10:25CrossRefGoogle Scholar
  17. Lepock JR (2003) Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperth 19:252–266CrossRefGoogle Scholar
  18. Lin G, Mi P, Chu C, Zhang J, Liu G (2016) Inorganic nanocarriers overcoming multidrug resistance for cancer theranostics. Adv Sci 3:1600134CrossRefGoogle Scholar
  19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25:402–408CrossRefGoogle Scholar
  20. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207CrossRefGoogle Scholar
  21. Mandl J, Szarka A, Bánhegyi G (2009) Vitamin C: update on physiology and pharmacology. Br J Pharmacol 157:1097–1110CrossRefGoogle Scholar
  22. Mehtala JG, Torrengrosa-Allen S, Elzey AD, Jeon M, Kim C, Wei A (2014) Synergetic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors. Nanomedicine 9:1939–1955CrossRefGoogle Scholar
  23. Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan S (2016) Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci Rep 6:27439CrossRefGoogle Scholar
  24. Moribe K, Limwikrant W, Higashi K, Yamamoto K (2011) Drug nanoparticle formulation using ascorbic acid derivatives. J Drug Deliv 138929:1–9CrossRefGoogle Scholar
  25. Peters GJ (2018) Cancer drug resistance: a new perspective. Cancer Drug Resist 1:1–5CrossRefGoogle Scholar
  26. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45CrossRefGoogle Scholar
  27. Pollard HB, Levine MA, Eidelman O, Pollard M (2010) Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer. In Vivo 24:249–256Google Scholar
  28. Quinto CA, Mohindra P, Tong S, Bao G (2015) Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. Nanoscale 7:12728–12736CrossRefGoogle Scholar
  29. Sadhukha T, Niu L, Wiedmann TS, Panyam J (2013) Effective elimination of cancer stem cells by magnetic hyperthermia. Mol Pharm 10:1432–1441CrossRefGoogle Scholar
  30. Sampath D, Cortes J, Estrov Z, Du M, Shi Z, Andreeff M, Gandhi V, Plunkett W (2006) Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood 107:2517–2524CrossRefGoogle Scholar
  31. Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297CrossRefGoogle Scholar
  32. Soares PIP, Ferreira IMM, Igreja RAGBN., Novo CMM, Borges JPMR. (2012) Application of hyperthermia for cancer treatment: recent patents review. Recent Pat Anticancer Drug Discov 7:64–73CrossRefGoogle Scholar
  33. Vishwakarma SK, Bardia A, Paspala SAB, Khan AA (2015) Magnetic nanoparticle tagged stem cell transplantation in spinal cord injury: a promising approach for targeted homing of cells at the lesion site. Neurol India 63:460–461CrossRefGoogle Scholar
  34. Vishwakarma SK, Sharmila P, Bardia A, Chandrakala L, Raju N, Sravani G, Sastry BVS, Habeeb MA, Khan AA, Dhayal M (2017) Use of biocompatible sorafenib-gold nanoconjugates for reversal of drug resistance in human hepatoblastoma. Cells Sci Rep 7:8539CrossRefGoogle Scholar
  35. Vishwakarma SK, Bardia A, Lakkireddy C, Paspala SAB, Habeeb MA, Khan AA (2018) Real-time cellular and molecular dynamics of bi-metallic self-therapeutic nanoparticle in cancer cells. Appl Nanosci 8:115–124CrossRefGoogle Scholar
  36. Wen L, Yang S, Zhong J, Zhou Q, Xing D (2017) Thermoacoustic imaging and therapy guidance based on ultra-short pulsed microwave pumped thermoelastic effect induced with superparamagnetic iron oxide nanoparticles. Theranostics 7:1976–1989CrossRefGoogle Scholar
  37. Wo F, Xu R, Shao Y, Zhang Z, Chu M, Shi D, Liu S (2016) A multimodel system with synergetic effects of magneto-mechanical, photothermal, photodynamic and chemo therapies of cancer in grapheme-quantum dot-coated hollow magnetic nanospheres. Theranostics 6:485–500CrossRefGoogle Scholar
  38. Zahreddine H, Borden KLB (2013) Mechanisms and insights into drug resistance in cancer. Front Pharmacol 4:28CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Sandeep Kumar Vishwakarma
    • 1
    • 2
  • Chandrakala Lakkireddy
    • 1
    • 2
  • Tuba Marjan
    • 1
    • 2
  • Anjum Fatima
    • 1
    • 2
  • Avinash Bardia
    • 1
    • 2
  • Syed Ameer Basha Paspala
    • 1
    • 2
  • Md. Aejaz Habeeb
    • 1
    • 2
  • Aleem Ahmed Khan
    • 1
    • 2
  1. 1.Central Laboratory for Stem Cell Research and Translational Medicine, Centre for Liver Research and DiagnosticsDeccan College of Medical SciencesHyderabadIndia
  2. 2.Dr. Habeebullah Life SciencesHyderabadIndia

Personalised recommendations